Breaking News, Trials & Filings

WuXi STA Opens Its First Parental Formulation Manufacturing Line

Features multiple filling modules and a built-in lyophilizer to fill vials, syringes, and cartridges, as well as to produce lyophilized powders.

Author Image

By: Charlie Sternberg

Associate Editor

WuXi STA, a subsidiary of WuXi AppTec, has announced its first parenteral formulation manufacturing line at the Wuxi city site is now in commission. This wholly automatic sterile manufacturing line operates in a full isolation system with an annual capacity of 2 million units.    The automatic parenteral filling line features multiple filling modules and a built-in lyophilizer to fill vials, syringes, and cartridges of a full range of sizes, as well as to produce lyophilized powders. Different...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters